Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Syros Pharmaceuticals
Biotech
Syros buys Tyme, securing $190M to extend cash runway into 2025
By merging with the floundering Tyme and tapping investors including Flagship, Syros has extended its cash runway out into 2025.
Nick Paul Taylor
Jul 5, 2022 9:40am
Syros targets KRAS-mutant cancer with CDK7 inhibitor
Sep 20, 2021 11:30am
Syros links SY-1425 combo to 50%-plus AML complete response rate
Oct 25, 2019 10:15am
Syros cans solid tumor drug after seeing early clinical data
Oct 17, 2019 8:48am
A new approach to resistant prostate cancer
Aug 29, 2019 9:00am
Syros tanks on single-digit response rate in AML, MDS trial
Dec 11, 2017 8:58am